Drugs / levodopa/carbidopa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00906828 Comparator | Oct 2008 → Nov 2009 | Parkinson disease | Uppsala University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | levodopa/carbidopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00906828 ↗ |
| Route | Other | “intestinal gel, continuous infusion (daytime or 24-hour)” NCT00906828 ↗ |